Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ANDRX TO FILE SEVEN TO 10 ANDAs FOR CONTROLLED RELEASE GENERICS

Executive Summary

ANDRX TO FILE SEVEN TO 10 ANDAs FOR CONTROLLED RELEASE GENERICS "during the second half of 1994 and the first quarter of 1995," the Ft. Lauderdale-based company said in a March 23 prospectus for an initial public offering. Andrx has 15 generics under development, eight of which are expected to be licensed in the U.S. to other firms.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS024291

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel